Hacina J Gill1, Brooke G K MacLeod1, Noah Tregobov1

  • 1Centre for Cardiovascular Innovation, St. Paul's and Vancouver General Hospital, Vancouver, British Columbia, Canada; Cardiovascular Translational Laboratory, Providence Research & Centre for Heart Lung Innovation, Vancouver, British Columbia, Canada; Centre for Heart Valve Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.

PubMed
概括

在TAVR后,穿透导管心脏门 (THV) 中纤维组织的内生常见,可能会阻碍冠状动脉接入和新洗. 这种病理可能会使未来的手术复杂化,如重复TAVR.